These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 35672728)
21. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482 [TBL] [Abstract][Full Text] [Related]
22. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP]. Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253 [TBL] [Abstract][Full Text] [Related]
23. LDLR promotes autophagy-mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway. Liu L; Sun YH; An R; Cheng RJ; Li N; Zheng JH Kaohsiung J Med Sci; 2023 Aug; 39(8):779-788. PubMed ID: 37218642 [TBL] [Abstract][Full Text] [Related]
24. Polypeptide LTX-315 reverses the cisplatin chemoresistance of ovarian cancer cells via regulating Beclin-1/PI3K/mTOR signaling pathway. Ma J; Liu L; Ling Y; Zheng J J Biochem Mol Toxicol; 2021 Sep; 35(9):e22853. PubMed ID: 34309113 [TBL] [Abstract][Full Text] [Related]
25. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model. Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326 [TBL] [Abstract][Full Text] [Related]
26. HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells. Li Y; Sun J; Gao S; Hu H; Xie P Gene; 2018 Jul; 663():9-16. PubMed ID: 29660518 [TBL] [Abstract][Full Text] [Related]
27. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells Yang H; Li H; Lu S; Shan S; Guo Y Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608 [TBL] [Abstract][Full Text] [Related]
28. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2. Xu L; Zhang B; Li W Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576437 [TBL] [Abstract][Full Text] [Related]
29. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
30. [IL-17A/lL-17RA reduces cisplatin sensitivity of ovarian cancer SKOV3 cells by regulating autophagy]. Wang L; Zhang X; Wang L; Wang B; Zhang J; Li Y Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1550-1556. PubMed ID: 33243748 [TBL] [Abstract][Full Text] [Related]
31. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment. Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825 [TBL] [Abstract][Full Text] [Related]
32. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions. Ju X; Yu H; Liang D; Jiang T; Liu Y; Chen L; Dong Q; Liu X Biomed Pharmacother; 2018 Jun; 102():549-554. PubMed ID: 29597088 [TBL] [Abstract][Full Text] [Related]
33. The Hedgehog signaling pathway promotes chemotherapy resistance via multidrug resistance protein 1 in ovarian cancer. Zhang H; Hu L; Cheng M; Wang Q; Hu X; Chen Q Oncol Rep; 2020 Dec; 44(6):2610-2620. PubMed ID: 33125122 [TBL] [Abstract][Full Text] [Related]
34. EEF1D overexpression promotes osteosarcoma cell proliferation by facilitating Akt-mTOR and Akt-bad signaling. Cheng DD; Li SJ; Zhu B; Zhou SM; Yang QC J Exp Clin Cancer Res; 2018 Mar; 37(1):50. PubMed ID: 29510727 [TBL] [Abstract][Full Text] [Related]
35. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells]. Liu Y; Chen X; Luo Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280 [TBL] [Abstract][Full Text] [Related]
36. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo. Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949 [TBL] [Abstract][Full Text] [Related]
37. Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment. Li L; Li L; Hu L; Li T; Xie D; Liu X Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476500 [TBL] [Abstract][Full Text] [Related]
38. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754 [TBL] [Abstract][Full Text] [Related]
39. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism]. Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457 [No Abstract] [Full Text] [Related]
40. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving. Wang DY; Li N; Cui YL Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]